Aboleris PharmaListed
No domain yetbiotech_life_sciences
Aboleris Pharma is a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune diseases and organ transplantation rejection. We…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Aboleris Pharma is a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune diseases and organ transplantation rejection. We…
Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases, focusing on Nck modulators…
ARTHEx Biotech is a clinical-stage biotechnology company focused on developing RNA-based therapeutics targeting neuromuscular disorders, particularly Myotonic Dystrophy Type 1.
Cytospire Therapeutics is a biopharmaceutical company focused on developing innovative therapies.
NephroDI Therapeutics is a pharmaceutical company focusing on concentration disorders of the kidney, specifically developing an oral drug to treat Nephrogenic Diabetes Insipidus (…
Teitur Trophics is a biotechnology company focused on developing novel treatments for neurodegenerative diseases, particularly Parkinson's disease, through innovative therapies th…
Theolytics is developing systemically deliverable immunotherapies based on oncolytic adenoviruses designed to break through the barriers of solid tumours. Their lead candidate, TH…
VarmX is focused on developing VMX-C001, a breakthrough universal bypassing agent aimed at restoring blood coagulation in patients taking Factor Xa Direct Oral Anticoagulants (FXa…
Breye Therapeutics is focused on developing orally administered therapies for patients with deteriorating vision from retinal vascular diseases, particularly diabetic retinopathy…
AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
BOOST Pharma is a clinical-stage biotech company developing BT-101 for children with severe Osteogenesis Imperfecta (OI). The company builds on scientific work originating at Karo…